Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer

Clinical trial NCT01581970 · COMPLETED

Trial details

NCT number: NCT01581970
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2012-06-01
Primary completion: 2015-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.